Chemokines and Relevant microRNAs in the Atherogenic Process

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Immunology

Background:

• Chemokines are crucial in atherogenesis, mediating leukocyte adhesion and monocyte infiltration.
• Chemokines also regulate progenitor cell homeostasis and homing.
• MicroRNAs (miRs) have emerged as key regulators of chemokine expression and activity in vascular cells.

Purpose of the Study:

• To explore the intricate relationship between miRs and chemokines in atherosclerosis.
• To elucidate the roles of specific miRs (miR-181, miR-126, miR-155) in regulating pro- and anti-atherogenic chemokines.
• To identify potential therapeutic targets for atherosclerosis based on miR-chemokine interactions.

Main Methods:

• Review and analysis of existing literature on miR and chemokine roles in atherogenesis.
• Examination of specific miR-mediated regulation of chemokines like CXCL1, CXCL12, and CCL2 in endothelial cells, VSMCs, and macrophages.
• Discussion of the complex network formed by chemokines, their receptors, and miRs.

Main Results:

• miR-181 suppresses pro-atherogenic CXCL1 by down-regulating NF-kB in endothelial cells.
• miR-126 promotes re-endothelialization and lesion stability via a CXCL12 feedback loop.
• miR-155 is pro-atherogenic, inducing CCL2 in macrophages.

Conclusions:

• Chemokines, their receptors, and miRs form a complex regulatory network in vascular cells during atherogenesis.
• Specific miRs exert opposing effects, highlighting their multifaceted roles.
• Further understanding of miR-chemokine interactions may lead to novel atherosclerosis treatments.